Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care 2024;47(Suppl. 1):S158-S178

In the article cited above, the content in Table 9.2 regarding clinical considerations for the class of medications glucagon-like peptide 1 receptor agonists (GLP1-RAs) has been amended to reflect counseling patients about potential for ileus for all medications in this class. The original content for clinical considerations for GLP1-RAs appeared as follows:"Counsel patients about potential for ileus (semaglutide SQ)" The revised content for clinical considerations for GLP1-RAs now reads:"Counsel patients about potential for ileus" The online version of Section 9 (https://doi.org/10.2337/dc24-S009) has been updated with the revised text.